VCH-916

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 526822

CAS#: 1200133-34-1

Description: VCH-916 is a HCV NS5B polymerase inhibitor.


Price and Availability

Size
Price

Size
Price

Size
Price

VCH-916 is not in stock, but may be available through custom synthesis. For cost-effective reason, minimum 1 gram order is requested. The product will be characterized by NMR, HPLC and MS analysis. Purity (HPLC) is usually >98%. CoA, QC data, MSDS will be provided when product is successfully made. The estimated lead time is 2-3 months. Please send email to sales@medkoo.com to inquire quote.


Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 526822
Name: VCH-916
CAS#: 1200133-34-1
Chemical Formula: C26H36KNO4S
Exact Mass:
Molecular Weight: 497.7353
Elemental Analysis: C, 62.74; H, 7.29; K, 7.86; N, 2.81; O, 12.86; S, 6.44


Synonym: VCH-916; VCH 916; VCH916.

IUPAC/Chemical Name: potassium 5-(cyclohex-1-en-1-yl)-3-((1r,4R)-N-((1r,4R)-4-methoxycyclohexyl)-4-methylcyclohexane-1-carboxamido)thiophene-2-carboxylate

InChi Key: RYXIBQLRUHDYEE-CMYQJZBSSA-M

InChi Code: InChI=1S/C26H37NO4S.K/c1-17-8-10-19(11-9-17)25(28)27(20-12-14-21(31-2)15-13-20)22-16-23(32-24(22)26(29)30)18-6-4-3-5-7-18;/h6,16-17,19-21H,3-5,7-15H2,1-2H3,(H,29,30);/q;+1/p-1/t17-,19-,20-,21-;

SMILES Code: C[C@H]1CC[C@@H](CC1)C(N([C@@H]2CC[C@H](CC2)OC)C3=C(SC(C4=CCCCC4)=C3)C([O-])=O)=O.[K+]


Technical Data

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO

Shelf Life:
>2 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

Harmonized System Code:
293490


References

1: De Clercq E. Current race in the development of DAAs (direct-acting antivirals) against HCV. Biochem Pharmacol. 2014 Jun 15;89(4):441-52. doi: 10.1016/j.bcp.2014.04.005. Epub 2014 Apr 13. PubMed PMID: 24735613.